Related Experiment Videos
Vestibular schwannoma presenting as sudden deafness
1Department of Otolaryngology, School of Medicine, Keio University, Tokyo, Japan. yas712@mc.med.keio.ac.jp
The Journal of Laryngology and Otology
|October 12, 2000
Summary
Sudden deafness in vestibular schwannoma patients can improve, with hearing recovery linked to pure-tone average and tumor size. Auditory brain stem response findings suggest varied causes for sudden hearing loss in these cases.
Area of Science:
- Neuroscience
- Otolaryngology
- Audiology
Background:
- Vestibular schwannoma, a benign tumor of the vestibulocochlear nerve, can present with sudden deafness.
- Sudden sensorineural hearing loss (SSNHL) is a critical symptom requiring prompt evaluation.
- Understanding the factors influencing hearing recovery in SSNHL associated with vestibular schwannoma is crucial for patient management.
Purpose of the Study:
- To analyze the clinical and audiological features of vestibular schwannoma patients with sudden deafness.
- To evaluate the relationship between prognostic factors and hearing loss outcomes.
- To investigate the role of tumor size, pure-tone average (PTA), dizziness, and auditory brain stem response (ABR) in hearing recovery.
Main Methods:
- Retrospective analysis of 24 patients with vestibular schwannoma and sudden deafness presenting within 10 days of onset.
- Assessment of pure-tone average (PTA), presence of dizziness/vertigo, tumor size, and auditory brain stem response (ABR) findings.
- Correlation of these features with hearing loss prognosis and recovery.
Main Results:
- Hearing recovery was dependent on PTA and tumor size.
- Even small vestibular schwannomas could induce sudden deafness.
- Complete hearing recovery occurred in 5 out of 24 patients.
- ABR findings suggested diverse etiologies for sudden deafness in this patient cohort.
Conclusions:
- Prognosis for hearing loss in vestibular schwannoma-associated sudden deafness is influenced by PTA and tumor size.
- Vestibular schwannoma should be considered in the differential diagnosis of SSNHL, regardless of tumor size.
- The varied ABR findings highlight the need for individualized assessment and treatment strategies.